These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1840060)

  • 21. Topical provocation of fixed drug eruption due to sulphamethoxazole.
    Oleaga JM; Aguirre A; González M; Diaz-Pérez JL
    Contact Dermatitis; 1993 Sep; 29(3):155. PubMed ID: 8222629
    [No Abstract]   [Full Text] [Related]  

  • 22. Oral mucosal fixed drug eruption: characteristics and differential diagnosis.
    Özkaya E
    J Am Acad Dermatol; 2013 Aug; 69(2):e51-8. PubMed ID: 23044075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fixed drug eruption - a sexually inducible reaction?
    Zawar V; Kirloskar M; Chuh A
    Int J STD AIDS; 2004 Aug; 15(8):560-3. PubMed ID: 15307969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical study of cutaneous drug eruptions in 200 patients.
    Raksha MP; Marfatia YS
    Indian J Dermatol Venereol Leprol; 2008; 74(1):80. PubMed ID: 18193504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple fixed drug eruptions (MFDE) following continuous cotrimoxazole (TMP + SMZ) therapy.
    Sehgal VN; Bhattacharya SN
    J Dermatol; 1997 Jun; 24(6):410-1. PubMed ID: 9241971
    [No Abstract]   [Full Text] [Related]  

  • 26. A three-year-analysis of fixed drug eruptions in hospital settings in France.
    Brahimi N; Routier E; Raison-Peyron N; Tronquoy AF; Pouget-Jasson C; Amarger S; Machet L; Amsler E; Claeys A; Sassolas B; Leroy D; Grange A; Dupuy A; Cordel N; Bonnetblanc JM; Milpied B; Doutre MS; Guinnepain MT; Barbaud A; Chosidow O; Roujeau JC; Lebrun-Vignes B; Descamps V
    Eur J Dermatol; 2010; 20(4):461-4. PubMed ID: 20507840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fixed drug eruptions. A study of 20 occurrences in Singapore.
    Chan HL
    Int J Dermatol; 1984 Nov; 23(9):607-9. PubMed ID: 6240472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trimethoprim associated fixed drug eruption.
    Hughes BR; Holt PJ; Marks R
    Br J Dermatol; 1987 Feb; 116(2):241-2. PubMed ID: 2950916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unilateral non-pigmenting fixed drug eruption associated with cotrimoxazole.
    Rasi A; Khatami A
    Dermatol Online J; 2006 Oct; 12(6):12. PubMed ID: 17083892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Situ Patch Test and Repeated Open Application Test for Fixed Drug Eruption: A Multicenter Study.
    Traineau H; Milpied B; Soria A; Assier H; Tetart F; Bernier C; Le Bouëdec MF; Gener G; Kurihara F; Bauvin O; Delauney J; Amsler E; Bara C; Pelletier F; Valois A; Castelain F; de Risi Pugliese T; Hamelin A; Barbaud A
    J Allergy Clin Immunol Pract; 2024 Feb; 12(2):460-468. PubMed ID: 37863314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical provocation of fixed drug eruption.
    Alanko K; Stubb S; Reitamo S
    Br J Dermatol; 1987 Apr; 116(4):561-7. PubMed ID: 2953388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fixed drug eruptions: presentation, diagnosis, and management.
    Flowers H; Brodell R; Brents M; Wyatt JP
    South Med J; 2014 Nov; 107(11):724-7. PubMed ID: 25365443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fixed drug eruptions - the common and novel culprits since 2000.
    McClatchy J; Yap T; Nirenberg A; Scardamaglia L
    J Dtsch Dermatol Ges; 2022 Oct; 20(10):1289-1302. PubMed ID: 36210056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fixed drug eruptions in children.
    Tarim O; Eralp O; Uncu Y
    J Pediatr; 2000 Apr; 136(4):565-6. PubMed ID: 10753268
    [No Abstract]   [Full Text] [Related]  

  • 35. Topical provocation in 31 cases of fixed drug eruption: change of causative drugs in 10 years.
    Lee AY
    Contact Dermatitis; 1998 May; 38(5):258-60. PubMed ID: 9667442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective study of cutaneous drug reactions.
    Puavilai S; Timpatanapong P
    J Med Assoc Thai; 1989 Mar; 72(3):167-71. PubMed ID: 2525591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-reactivity among p-amino group compounds in sulfonamide fixed drug eruption: diagnostic value of patch testing.
    Tornero P; De Barrio M; Baeza ML; Herrero T
    Contact Dermatitis; 2004 Aug; 51(2):57-62. PubMed ID: 15373844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fixed drug eruption caused by sulfaguanidine.
    Arias J; Fernández-Rivas M; Martinez M; Senent C
    Dermatology; 1994; 189(2):196-7. PubMed ID: 8075454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous reactions to drugs: a series of in-patients during a five-year period.
    Stubb S; Heikkilä H; Kauppinen K
    Acta Derm Venereol; 1994 Jul; 74(4):289-91. PubMed ID: 7976089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bullous fixed drug eruption masquerading as recurrent Stevens Johnson syndrome.
    Dharamsi FM; Michener MD; Dharamsi JW
    J Emerg Med; 2015 May; 48(5):551-4. PubMed ID: 25433836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.